APB’s SCM obtains GMP certification
The Medicines Control Service (SCM) of APB has officially obtained GMP certification (Good Manufacturing Practices).
This certification confirms that SCM complies with recognized european and international standards for quality, safety and traceability applicable to medicinal products and clinical research activities. The analytical services provided through Phasius are delivered within a compliant, auditable and verifiable framework.
Activities covered by the GMP certification
The GMP certificate covers activities related to Investigational Medicinal Products (IMPs), including:
· Sterility testing,
· Microbiological testing of non-sterile products,
· Physico-chemical quality control,
· Biological analyses.
This expertise also extends to non‑pharmaceutical industrial applications requiring a high level of analytical reliability.
MIA authorizations and GMP certificates
Using the reference numbers below, our partners can officially verify the validity and compliance of the GMP certification :
Official Manufacturing and Importation Authorizations (MIA)
· 1955H – Medicinal products for human use
· 1955V – Veterinary medicinal products
· 1955IMP – Investigational Medicinal Products
GMP certificates
· BE/GMP/2025/191 – Human use
· BE/GMP/2025/192 – Veterinary use
· BE/GMP/2025/193 – Investigational Medicinal Products
Recognized and specialized analytical expertise
With over 75 years of experience in analysis and quality control, APB’s SCM relies on in‑depth expertise within the Belgian pharmaceutical and hospital sectors.
This expertise forms the foundation of the analytical services offered to our partners through Intelacy.
Discover all the analytical techniques offered by Phasius.